| From: |
|
Alison Bunce - Medicines and Healthcare Products Regulatory Agency
|
|
|
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- NHS Trusts (England) - Medical Director
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Clinical Commissioning Groups
- NHS Foundation Trusts (England) - Chief Executive
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Director of Public Health
- NHS Trusts (England) - Chief Executive
|
| Action category: |
|
Class 2: Action within 48 hours
|
| Title: |
|
DRUG ALERT CLASS 2, ACTION WITHIN 48 HOURS, ACCORD-UK LTD IN ACTAVIS LIVERY, ARIPIPRAZOLE 1MG/ML ORAL SOLUTION
|
| Broadcast content: |
|
Accord-UK Ltd is recalling some batches of the above product because there is the potential for small particles of Aripiprazole active substance to be present.
| Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts |
|
| Cascade to: |
|
- #GP#
- #COMMUNITYPHARMACISTS#
- #DISPENSING GP#
- #HospitalPharmacy#
|